BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22391746)

  • 21. Humulone suppresses replication of respiratory syncytial virus and release of IL-8 and RANTES in normal human nasal epithelial cells.
    Fuchimoto J; Kojima T; Okabayashi T; Masaki T; Ogasawara N; Obata K; Nomura K; Hirakawa S; Kobayashi N; Shigyo T; Yokota S; Fujii N; Tsutsumi H; Himi T; Sawada N
    Med Mol Morphol; 2013 Dec; 46(4):203-9. PubMed ID: 23381605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling.
    McAllister CS; Ansaldi D; Growcott EJ; Zhong Y; Quackenbush D; Wolff KC; Chen Z; Tanaseichuk O; Lelais G; Barnes SW; Federe GC; Luna F; Walker JR; Zhou Y; Kuhen KL
    Virology; 2020 Jan; 540():195-206. PubMed ID: 31929001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potent inhibition of respiratory syncytial virus by combination treatment with 2-5A antisense and ribavirin.
    Xu Z; Kuang M; Okicki JR; Cramer H; Chaudhary N
    Antiviral Res; 2004 Mar; 61(3):195-206. PubMed ID: 15168801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces Respiratory Syncytial Virus Replication
    Jorquera PA; Mathew C; Pickens J; Williams C; Luczo JM; Tamir S; Ghildyal R; Tripp RA
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30541831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays.
    Zhang Y; Luxon BA; Casola A; Garofalo RP; Jamaluddin M; Brasier AR
    J Virol; 2001 Oct; 75(19):9044-58. PubMed ID: 11533168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in understanding respiratory syncytial virus infection in airway epithelial cells and consequential effects on the immune response.
    Lay MK; González PA; León MA; Céspedes PF; Bueno SM; Riedel CA; Kalergis AM
    Microbes Infect; 2013 Mar; 15(3):230-42. PubMed ID: 23246463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type-I interferons induce lung protease responses following respiratory syncytial virus infection via RIG-I-like receptors.
    Foronjy RF; Taggart CC; Dabo AJ; Weldon S; Cummins N; Geraghty P
    Mucosal Immunol; 2015 Jan; 8(1):161-75. PubMed ID: 25005357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor.
    Coates M; Brookes D; Kim YI; Allen H; Fordyce EAF; Meals EA; Colley T; Ciana CL; Parra GF; Sherbukhin V; Stockwell JA; Thomas JC; Hunt SF; Anderson-Dring L; Onions ST; Cass L; Murray PJ; Ito K; Strong P; DeVincenzo JP; Rapeport G
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium.
    Villenave R; Broadbent L; Douglas I; Lyons JD; Coyle PV; Teng MN; Tripp RA; Heaney LG; Shields MD; Power UF
    J Virol; 2015 Dec; 89(24):12309-18. PubMed ID: 26423940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretreatment with a grape seed proanthocyanidin extract downregulates proinflammatory cytokine expression in airway epithelial cells infected with respiratory syncytial virus.
    Kim SJ; Lee JW; Eun YG; Lee KH; Yeo SG; Kim SW
    Mol Med Rep; 2019 Apr; 19(4):3330-3336. PubMed ID: 30816467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imiquimod suppresses respiratory syncytial virus (RSV) replication via PKA pathway and reduces RSV induced-inflammation and viral load in mice lungs.
    Salinas FM; Nebreda AD; Vázquez L; Gentilini MV; Marini V; Benedetti M; Nabaes Jodar MS; Viegas M; Shayo C; Bueno CA
    Antiviral Res; 2020 Jul; 179():104817. PubMed ID: 32387475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substituted N-(4-amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide analogues potently inhibit respiratory syncytial virus (RSV) replication and RSV infection-associated inflammatory responses.
    Xu J; Wu W; Chen H; Xue Y; Bao X; Zhou J
    Bioorg Med Chem; 2021 Jun; 39():116157. PubMed ID: 33895704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo.
    Miller AL; Bowlin TL; Lukacs NW
    J Infect Dis; 2004 Apr; 189(8):1419-30. PubMed ID: 15073679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late therapeutic intervention with a respiratory syncytial virus L-protein polymerase inhibitor, PC786, on respiratory syncytial virus infection in human airway epithelium.
    Brookes DW; Coates M; Allen H; Daly L; Constant S; Huang S; Hows M; Davis A; Cass L; Ayrton J; Knowles I; Strong P; Rapeport G; Ito K
    Br J Pharmacol; 2018 Jun; 175(12):2520-2534. PubMed ID: 29579332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Grape Seed Proanthocyanidin Inhibits Mucin Synthesis and Viral Replication by Suppression of AP-1 and NF-κB via p38 MAPKs/JNK Signaling Pathways in Respiratory Syncytial Virus-Infected A549 Cells.
    Lee JW; Kim YI; Im CN; Kim SW; Kim SJ; Min S; Joo YH; Yim SV; Chung N
    J Agric Food Chem; 2017 Jun; 65(22):4472-4483. PubMed ID: 28502165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human cathelicidin, LL-37, inhibits respiratory syncytial virus infection in polarized airway epithelial cells.
    Harcourt JL; McDonald M; Svoboda P; Pohl J; Tatti K; Haynes LM
    BMC Res Notes; 2016 Jan; 9():11. PubMed ID: 26732674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential antiviral activities of respiratory syncytial virus (RSV) inhibitors in human airway epithelium.
    Mirabelli C; Jaspers M; Boon M; Jorissen M; Koukni M; Bardiot D; Chaltin P; Marchand A; Neyts J; Jochmans D
    J Antimicrob Chemother; 2018 Jul; 73(7):1823-1829. PubMed ID: 29596680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Respiratory syncytial virus activates epidermal growth factor receptor to suppress interferon regulatory factor 1-dependent interferon-lambda and antiviral defense in airway epithelium.
    Kalinowski A; Galen BT; Ueki IF; Sun Y; Mulenos A; Osafo-Addo A; Clark B; Joerns J; Liu W; Nadel JA; Dela Cruz CS; Koff JL
    Mucosal Immunol; 2018 May; 11(3):958-967. PubMed ID: 29411775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autocrine regulation and experimental modulation of interleukin-6 expression by human pulmonary epithelial cells infected with respiratory syncytial virus.
    Jiang Z; Kunimoto M; Patel JA
    J Virol; 1998 Mar; 72(3):2496-9. PubMed ID: 9499112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).
    Elliott MB; Tebbey PW; Pryharski KS; Scheuer CA; Laughlin TS; Hancock GE
    J Med Virol; 2004 Jun; 73(2):300-8. PubMed ID: 15122808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.